Navigation Links
Inovio Pharmaceuticals to Present at Scientific Conferences
Date:3/29/2011

sults achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will provide the company with meaningful protection from others using the covered technologies, whether such proprietary rights are enforceable or defensible or infringe or allegedly infringe on rights of others or can withstand claims of invalidity and whether the company can finance or devote other significant resources that may be necessary to prosecute, protect or defend them, the level of corporate expenditures, assessments of the company's technology by potential corporate or other partners or collaborators, capital market conditions, our ability to successfully integrate Inovio and VGX Pharmaceuticals, the impact of government healthcare proposals and other factors set forth in our Annual Report on Form 10-K for the year ended December 31, 2010 and other regulatory filings from time to time. There can be no assurance that any product in Inovio's pipeline will be successfully developed or manufactured, that final results of clinical studies will be supportive of regulatory approvals required to market licensed products, or that any of the forward-looking information provided herein will be proven accurate.

CONTACTS:Investors: Bernie Hertel, Inovio Pharmaceuticals 858-410-3101 bhertel@inovio.com

Media
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development
2. Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
3. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
4. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
5. Inovio Pharmaceuticals Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovios Electroporation Delivery Technology
6. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
7. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
8. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
9. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
10. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
11. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014   Santa Clara dentist , Dr. ... promotion for Invisalign. Invisalign is an orthodontic system that ... is often the orthodontic treatment of choice for older ... of it. For a limited time, patients can try ... from the usual cost. This offer cannot be combined, ...
(Date:9/2/2014)... Spain , September 2, 2014 ... at ESC CONGRESS 2014 provide insight into treatment ... in everyday clinical practice --   ... Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF), ... that stroke prevention strategies for atrial fibrillation (AF) ...
(Date:9/2/2014)... -- Ortho Development® Corporation (ODEV) has received FDA ... addition to its growing hip replacement product line. ... in total hip arthroplasty and hemiarthroplasty procedures. ... Alpine was developed based on the clinically-proven, ... closely with a select team of orthopedic surgeons ...
Breaking Medicine Technology:Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 3Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 4Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 5Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 6Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 7Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 8Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 9Ortho Development Receives FDA Clearance for Alpine Hip Stem 2
... R.I., June 13, 2011 CVS Caremark Corporation (NYSE: ... executive vice president and chief financial officer of CVS ... the Jeffries 2011 Global Consumer Conference on June 22, ... AM EDT. (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO ) ...
... Henry Schein, Inc., (NASDAQ: HSIC ), the ... practitioners, announced today that Stanley M. Bergman, Chairman ... the Company,s Executive Vice President and Chief Financial Officer, will ... is taking place at the Four Seasons Hotel in Chicago. ...
Cached Medicine Technology:CVS Caremark to Present at the Jefferies 2011 Global Consumer Conference 2Henry Schein to Present at the William Blair 31st Annual Growth Stock Conference 2
(Date:9/2/2014)... 2, 2014 (HealthDay News) -- Complications are rare ... reconstruction, a new study indicates. However, the ... associated with a slightly higher risk for certain ... included more than 18,000 breast cancer patients who ... mastectomy with breast reconstruction and were followed for ...
(Date:9/2/2014)... return to the emergency department within a few days of ... symptoms and have lost trust in other parts of the ... published online today in Annals of Emergency Medicine ... ). , "When asked why they did not ... symptoms were too severe to wait until their scheduled appointment ...
(Date:9/2/2014)... Sept. 2, 2014 (HealthDay News) -- Two new studies ... suggests that 6-year-olds who were breast-fed have a lower ... bottle-fed infants, while the other finds a similar trend ... the "many benefits of breast-feeding in the immediate newborn ... Hill Hospital in New York City. She was not ...
(Date:9/2/2014)... -- Drinking and marijuana may lead to different types ... Researchers analyzed 2007 to 2011 data gathered from ... they had used alcohol or marijuana at least once. ... with more unsafe driving, damage to relationships with friends ... the influence of alcohol, especially among females. ...
(Date:9/2/2014)... Anti-aging is proving to be ... as anti-wrinkle treatments and products, hair restoration treatments, ... augmentation becoming much sought after worldwide. In a ... firm Transparency Market Research, the global market for ... USD 191.7 billion by 2019, from being worth ...
Breaking Medicine News(10 mins):Health News:Complication Rates Low With Mastectomy, Breast Reconstruction: Study 2Health News:Discharged patients return to the ER because 'better safe than sorry' 2Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2Health News:Booze, Pot Bad for Teens in Different Ways, Study Suggests 2Health News:Global Anti-aging Market Research Report 2018 by Transparency Market Research 2Health News:Global Anti-aging Market Research Report 2018 by Transparency Market Research 3
... the same-sex marriage, has said she would prefer to stay ... their marriage ends. ,Recording her statement before civil ... abducted by anyone, adding that their marriage took place with ... be his life partner and he responded to my proposal ...
... and the Institute for the Study of Labour has revealed ... ,In the study of 1000 adults in Germany, the ... of 100 euros today or 150 euros in a year's ... measured the cognitive abilities of the participants, using two different ...
... seen the first-ever signs of a drop in new ... country with the world's second-heaviest AIDS burden. ... HIV prevalence among pregnant women had dropped to 29.1 ... Manto Tshabalala-Msimang told journalists in Pretoria. ,"The ...
... School of Medicine in St. Louis, Missouri, have found ... to treatments for deadliest poisons like Ricin, cholera toxin, ... deadly strains of E. coli bacteria, these toxins travel ... Golgi network and endoplasmic reticulum before interrupting protein synthesis. ...
... Committee on Economic Affairs (CCEA) today gave its approval ... (RNTCP) for five years - - from April ... of Chhattisgarh, Jharkhand and Uttranchal. ,The CCEA also ... project - - Andhra Pradesh, Chandigarh, Haryana, Maharashtra, Punjab ...
... are a group of five large lakes in North America ... largest group of fresh water lakes on Earth. ... levels of toxic chemicals in the lakes are alarmingly high. ... Great Lakes Fish, analyzed the fish advisories published by the ...
Cached Medicine News:Health News:People With Higher IQs are More Patient in Financial Matters 2Health News:Great Lakes Fish in Canada Heavily Polluted 2Health News:Great Lakes Fish in Canada Heavily Polluted 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
The GII titanium anchor with nitinol arcs is used for soft tissue reattachment to bone. The GII's small size, high pull-out strength and wide range of clinical applications make it the anchor used by...
Medicine Products: